Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II

Brianna Yund1, Kyle Rudser2, Alia Ahmed1

  • 1Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Abstract

Insights

Attention is compromised in attenuated mucopolysaccharidosis type II (MPS II), or Hunter syndrome, despite average intelligence. White matter and corpus callosum abnormalities are linked to attention deficits in these patients.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • The attenuated phenotype of mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is not well-characterized, particularly regarding potential mild cognitive or behavioral impairments.
  • While severe MPS II involves significant cognitive deficits, the impact of the attenuated form on long-term functional outcomes remains unclear.
  • Previous studies indicate MRI abnormalities, including white matter changes, in MPS II patients.

Purpose of the Study:

  • To investigate the association between brain volumes, somatic disease burden, and neuropsychological outcomes in patients with attenuated MPS II.
  • To compare brain volumes in patients with attenuated MPS II to those of normal controls.

Main Methods:

  • Cross-sectional analysis of a longitudinal study involving 20 patients with attenuated MPS II (mean age 15.8).
  • Neuropsychological assessments included measures of intelligence, memory, and attention.
  • Brain MRI volumes were analyzed and compared to 55 age-matched normal controls.

Main Results:

  • Patients with attenuated MPS II demonstrated average IQ and memory but attention measures were one standard deviation below average.
  • Corpus callosum volumes were significantly smaller (22% difference) in MPS II patients compared to controls.
  • MPS II patients did not exhibit normal age-related white matter volume increases seen in controls.
  • Somatic disease burden, white matter, and corpus callosum volumes were significantly associated with attention deficits.

Conclusions:

  • Attention is impaired in attenuated MPS II, even with average intelligence.
  • Corpus callosum and white matter abnormalities, along with somatic disease burden, contribute to attention difficulties in MPS II.
  • Increased awareness and appropriate management are crucial for patients with attenuated MPS II.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1